Endocrinology · Diabetes Mellitus Complications
The facts most likely to be tested
DKA is characterized by the triad of hyperglycemia (>250 mg/dL), anion gap metabolic acidosis (pH <7.3, bicarbonate <18 mEq/L), and ketonemia or ketonuria.
The primary pathophysiology involves an absolute insulin deficiency leading to unchecked lipolysis and the production of beta-hydroxybutyrate and acetoacetate.
Patients typically present with Kussmaul respirations (deep, rapid breathing), fruity breath odor, and abdominal pain due to metabolic derangement.
Initial management requires aggressive intravenous fluid resuscitation with isotonic saline to restore intravascular volume and improve renal perfusion.
Intravenous regular insulin infusion is mandatory to suppress ketogenesis, but it must only be initiated after confirming a serum potassium level ≥3.3 mEq/L to prevent life-threatening hypokalemia.
The anion gap must be monitored for closure, and the transition to subcutaneous insulin should only occur once the patient is hemodynamically stable and the anion gap has normalized.
The most common precipitating factors for DKA are infection, non-compliance with insulin therapy, and new-onset Type 1 Diabetes Mellitus.
Vignette unlocked
A 19-year-old male with a history of Type 1 Diabetes presents to the emergency department with a 2-day history of nausea, vomiting, and diffuse abdominal pain. On physical exam, he is tachycardic, tachypneic with deep, rapid respirations, and has a fruity odor on his breath. Laboratory studies reveal a blood glucose of 450 mg/dL, a pH of 7.15, and a serum bicarbonate of 12 mEq/L. His serum potassium is 3.8 mEq/L.
What is the most appropriate next step in the management of this patient?
Intravenous fluid resuscitation and initiation of an insulin infusion
The patient meets the diagnostic criteria for DKA; since his potassium is >3.3 mEq/L, it is safe to initiate insulin therapy alongside aggressive fluid resuscitation to correct the metabolic acidosis.
Full handout
High yield triage
Etiology / Epidemiology
Primarily Type 1 Diabetes patients triggered by infection, non-compliance, or new-onset disease.
Clinical Manifestations
Classic Kussmaul breathing, fruity breath, and abdominal pain in a dehydrated patient.
Diagnosis
Serum beta-hydroxybutyrate is the gold standard; pH < 7.3 and glucose > 250 mg/dL.
Treatment
IV fluids (0.9% NS) followed by IV insulin; do not start insulin until K+ > 3.3 mEq/L.
Prognosis
Monitor for cerebral edema; mortality is low if anion gap closes and electrolytes are corrected.
Full handout
Epidemiology & Etiology
DKA is a life-threatening complication of Type 1 Diabetes resulting from absolute insulin deficiency. Common precipitating factors include the 5 I's: Infection, Ischemia (MI), Infarction, Intoxication, and Insulin omission.
Pertinent Anatomy
The metabolic derangement centers on the pancreatic beta cells failing to produce insulin. The resulting systemic state affects the renal tubules (osmotic diuresis) and the respiratory center (compensatory hyperventilation).
Pathophysiology
Absolute insulin deficiency leads to unchecked lipolysis, releasing free fatty acids into the liver. These are converted into ketone bodies (acetoacetate, beta-hydroxybutyrate), causing a high anion gap metabolic acidosis. Hyperglycemia induces an osmotic diuresis, leading to profound total body potassium depletion despite normal or elevated serum levels.
Clinical Manifestations
Patients present with Kussmaul breathing (deep, rapid respirations) to compensate for acidosis. Look for fruity breath (acetone), tachycardia, and dehydration. Altered mental status is a red flag for impending cerebral edema.
Diagnosis
The serum beta-hydroxybutyrate level is the most accurate diagnostic test. Diagnostic criteria include glucose > 250 mg/dL, pH < 7.3, bicarbonate < 15 mEq/L, and a positive anion gap.
Treatment
Initiate aggressive IV fluids (0.9% NS) to restore perfusion. Start IV regular insulin infusion only after confirming potassium > 3.3 mEq/L to avoid fatal arrhythmias. Add dextrose to IV fluids once glucose drops below 200 mg/dL to prevent hypoglycemia.
Prognosis
The primary goal is closing the anion gap. Cerebral edema is the most feared complication, particularly in pediatric patients. Monitor potassium levels hourly during the initial phase.
Differential Diagnosis
HHS: glucose > 600 mg/dL, minimal ketones, no acidosis
Alcoholic Ketoacidosis: low/normal glucose, history of binge drinking
Salicylate toxicity: respiratory alkalosis + metabolic acidosis
Starvation ketosis: mild ketosis, normal glucose
Lactic acidosis: elevated lactate, no ketones